Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapy

Morgan R Godin, Preeya K Gupta Department of Ophthalmology, Division of Cornea and Refractive Surgery, Duke University Eye Center, Durham, NC, USA Abstract: A new topical ophthalmic medication, lifitegrast 5%, was recently approved by the US Food and Drug Administration for use in dry eye patients...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Godin MR, Gupta PK
Format: article
Langue:EN
Publié: Dove Medical Press 2017
Sujets:
ODS
VAS
Accès en ligne:https://doaj.org/article/eccfef0b80344d40b251c2575f854896
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!